FDA issued a Warning Letter to Jazz Pharmaceuticals, Inc on 10/11/2011 for a previous inspection.
483 Jazz Pharmaceuticals Jan 2016

483 Jazz Pharmaceuticals Jan 2016

Thea Grome FDA$119.00 - Available Now

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued inspectional observations (via FDA 483) on 27 Jan 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Jan 2016
  • Location: Palo Alto, United States
  • FEI: 3005615655
Add To Cart